<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02671838</url>
  </required_header>
  <id_info>
    <org_study_id>US-01-2016</org_study_id>
    <nct_id>NCT02671838</nct_id>
  </id_info>
  <brief_title>A Musculoskeletal Ultrasound Program to Improve Disease Modifying Anti-Rheumatic Drugs Adherence in Rheumatoid Arthritis</brief_title>
  <official_title>Developing a Musculoskeletal Ultrasound Program as an Intervention to Improve Disease Modifying Anti-Rheumatic Drugs Adherence in Rheumatoid Arthritis: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Singapore General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Singapore General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-adherence to medications can lead to sub-optimal treatment in rheumatoid arthritis (RA)
      patients. In order to improve disease modifying anti-rheumatic drugs (DMARDs) adherence, the
      investigators are conducting a randomized controlled trial to test out an intervention to
      improve medications adherence among low adherers. This intervention involves the use of a
      musculoskeletal ultrasound program which allows RA patients to visualize their joint
      inflammation and damage real time while treatment adherence is simultaneously reinforced. In
      doing so, the investigators hope to improve patients' understanding of their joint disease
      and motivate the participants to adhere to their medications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single center randomized controlled clinical trial conducted in the Singapore
      General Hospital. Eligible RA subjects meeting the inclusion and exclusion criteria will be
      screened using a medication adherence measure questionnaire. Thereafter 132 patients who are
      low adherers on the questionnaire will then be recruited and randomized (in a 1:1 ratio) to
      either (a) intervention arm (with musculoskeletal US program) or (b) control arm (without
      musculoskeletal US program), and followed up over a period of about 6 month.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in proportion of patients with a low adherence score using medication adherence measure (questionnaire)</measure>
    <time_frame>baseline and 1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in proportion of patients with a low adherence score using medication adherence measure (questionnaire)</measure>
    <time_frame>baseline, 3 months and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in proportion of patients with a low adherence score using medication adherence measure (pharmacy dispense data)</measure>
    <time_frame>baseline, 1 month, 3months and 6 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in clinical follow-up defaults (e.g. how often patients do not show up for their clinic appointments)</measure>
    <time_frame>baseline, 3 months and 6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in clinical joint assessment outcomes(e.g. disease activity score 28)</measure>
    <time_frame>baseline, 3 months and 6 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Musculoskeletal ultrasound program</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants will receive the musculoskeletal ultrasound program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will not be receiving the musculoskeletal ultrasound program.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Musculoskeletal ultrasound program</intervention_name>
    <description>Using a musculoskeletal ultrasound program to help improve medication adherence</description>
    <arm_group_label>Musculoskeletal ultrasound program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female patients from 21 to 75 years old

          -  Underlying rheumatoid arthritis diagnosed using the 1987 or 2010 RA criteria

          -  On at least one of the following DMARDs (Methotrexate, Sulfasalazine,
             Hydroxychloroquine and/or Leflunomide)

        Exclusion Criteria:

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Singapore General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tan</last_name>
    <phone>62223322</phone>
  </overall_contact>
  <location>
    <facility>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Tan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2016</study_first_submitted>
  <study_first_submitted_qc>January 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2016</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antirheumatic Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

